A Non-Interventional Multi-Country Post-Authorisation Safety Study (PASS) to Assess the Incidence of Serious Infections & Malignancies in Systemic Lupus Erythematosus (SLE) Patients Exposed to Anifrolumab (SIMA PASS)

03/07/2023
02/07/2024
EU PAS number:
EUPAS105690
Study
Planned

ENCePP Code of conduct

No
Data sources

Data source(s)

Data source(s), other

SNDS France, SHI Germany

Data sources (types)

Administrative healthcare records (e.g., claims)
Drug dispensing/prescription data
Electronic healthcare records (EHR)
Other

Data sources (types), other

Hospital medication registries
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No